(Q84984843)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21946845%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

title

Chemotherapy: advanced NSCLC--should we use doublets in elderly patients? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21946845%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

author name string

Robert Pirker

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21946845%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

publication date

27 September 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21946845%20AND%20SRC:MED&resulttype=core&format=json

Nature Reviews Clinical Oncology

13 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21946845%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21946845%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21946845%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

page(s)

694-696

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21946845%20AND%20SRC:MED&resulttype=core&format=json

American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003.

13 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.147

Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.147

Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.147

Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.147

Gemcitabine plus vinorelbine versus vinorelbine alone in elderly patients with advanced non-small-cell lung cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.147

Chemotherapy for elderly patients with advanced non-small-cell lung cancer: the Multicenter Italian Lung Cancer in the Elderly Study (MILES) phase III randomized trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.147

Carboplatin and weekly paclitaxel doublet chemotherapy compared with monotherapy in elderly patients with advanced non-small-cell lung cancer: IFCT-0501 randomised, phase 3 trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.147

Benefits of Adding a Drug to a Single-Agent or a 2-Agent Chemotherapy Regimen in Advanced Non–Small-Cell Lung Cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.147

Platinum-based versus non-platinum-based chemotherapy in advanced non-small-cell lung cancer: a meta-analysis of the published literature

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.147

Effects of Vinorelbine on Quality of Life and Survival of Elderly Patients With Advanced Non-Small-Cell Lung Cancer

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21946845

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NRCLINONC.2011.147

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21946845%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

1 reference